Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Lung Stem Cell Transplantation in ILD
NCT02796781Phase 2Completed
- Sponsor
- Shanghai East Hospital
- Start
- Oct 2016
- Primary completion
- Aug 2020
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in interstitial lung disease (ILD), sponsored by Shanghai East Hospital. Primary endpoint: Diffusing Capacity of the Lung for Carbon Monoxide at 24 weeks. Started Oct 2016; status: completed.
02
Conditions
interstitial lung disease (ILD)
Beyond the preview
Go deeper on NCT02796781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02796781.